| Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors (NCT00114790) | Boneca Corporation | 2003-12-01 |
| Zinc Supplements in Lowering Cadmium Levels in Smokers (NCT00376987) | Wake Forest University Health Sciences | 2003-12-01 |
| Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00054561) | Eastern Cooperative Oncology Group | 2003-11-26 |
| Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia (NCT00101335) | Fox Chase Cancer Center | 2003-11-01 |
| Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer (NCT00090337) | Memorial Sloan Kettering Cancer Center | 2003-11-01 |
| Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer (NCT00093665) | Aichi Cancer Center | 2003-11-01 |
| Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy (NCT00898430) | Vanderbilt-Ingram Cancer Center | 2003-11-01 |
| Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer (NCT00483639) | Vanderbilt-Ingram Cancer Center | 2003-11-01 |
| Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer (NCT00077103) | Case Comprehensive Cancer Center | 2003-11-01 |
| Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor (NCT00079079) | NCIC Clinical Trials Group | 2003-10-27 |
| Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer (NCT00193284) | SCRI Development Innovations, LLC | 2003-10-01 |
| Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer (NCT00068237) | Radiation Therapy Oncology Group | 2003-08-01 |
| Optimized Intensity Modulated Irradiation for Head and Neck Cancer (NCT00580983) | University of Michigan Rogel Cancer Center | 2003-08-01 |
| Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor (NCT01684098) | Endocyte | 2003-08-01 |
| Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors (NCT00066651) | National Cancer Institute (NCI) | 2003-07-01 |
| ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer (NCT00242762) | AstraZeneca | 2003-07-01 |
| Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck (NCT00233636) | AstraZeneca | 2003-07-01 |
| Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract (NCT00453336) | University of Miami | 2003-06-01 |
| Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia (NCT00056004) | Barbara Ann Karmanos Cancer Institute | 2003-06-01 |
| Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia (NCT00099021) | National Cancer Institute (NCI) | 2003-06-01 |
| Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00114153) | University of Virginia | 2003-06-01 |
| Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities (NCT00130143) | The Dale & Frances Hughes Cancer Center | 2003-06-01 |
| Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00062387) | National Cancer Institute (NCI) | 2003-05-01 |
| The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers (NCT00230269) | Stanford University | 2003-05-01 |
| Randomized Amifostine For SCCHN (NCT00095927) | Dana-Farber Cancer Institute | 2003-05-01 |
| S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00054054) | SWOG Cancer Research Network | 2003-04-01 |
| Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases (NCT00062348) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-04-01 |
| Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers (NCT00230256) | Stanford University | 2003-04-01 |
| Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer (NCT01187472) | University of Chicago | 2003-03-01 |
| Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy (NCT00095836) | Massachusetts General Hospital | 2003-03-01 |
| Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants (NCT00898638) | Vanderbilt University Medical Center | 2003-02-13 |
| S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat (NCT00017173) | SWOG Cancer Research Network | 2003-02-01 |
| Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer (NCT00057785) | Radiation Therapy Oncology Group | 2003-02-01 |
| Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors (NCT00054977) | Galectin Therapeutics Inc. | 2003-02-01 |
| Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast (NCT00230295) | Stanford University | 2003-02-01 |
| Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer (NCT00060242) | Case Comprehensive Cancer Center | 2003-02-01 |
| Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer (NCT01185171) | University of Chicago | 2003-01-27 |
| Safety and Efficacy of RK0202 in Oral Mucositis (NCT00230191) | RxKinetix | 2003-01-01 |
| Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer (NCT00061906) | Ohio State University Comprehensive Cancer Center | 2003-01-01 |
| Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer (NCT00040807) | Eastern Cooperative Oncology Group | 2002-11-19 |
| Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation (NCT00313027) | Stanford University | 2002-11-01 |
| A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer (NCT00148122) | University of Michigan Rogel Cancer Center | 2002-11-01 |
| Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck (NCT00318890) | University of Alabama at Birmingham | 2002-10-01 |
| High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer (NCT00052429) | Memorial Sloan Kettering Cancer Center | 2002-09-01 |
| Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer (NCT00058006) | Northwestern University | 2002-09-01 |
| EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer (NCT00049140) | David M. Brizel, MD | 2002-08-01 |
| Imatinib Mesylate in Treating Patients With Salivary Gland Cancer (NCT00045669) | University Health Network, Toronto | 2002-07-01 |
| Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer (NCT00047008) | Radiation Therapy Oncology Group | 2002-07-01 |
| Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia (NCT00052611) | Dana-Farber Cancer Institute | 2002-06-01 |
| Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck (NCT00185835) | Stanford University | 2002-06-01 |
| Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer (NCT00042926) | Alliance for Clinical Trials in Oncology | 2002-05-01 |
| A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma (NCT01185158) | University of Chicago | 2002-05-01 |
| Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer (NCT00036881) | Alliance for Clinical Trials in Oncology | 2002-05-01 |
| EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202) (NCT00270790) | Mohan Suntharalingam | 2002-05-01 |
| Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer (NCT00230308) | Stanford University | 2002-04-02 |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (NCT00310115) | M.D. Anderson Cancer Center | 2002-04-01 |
| Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients (NCT00168181) | Alberta Health services | 2002-04-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00639769) | Vanderbilt-Ingram Cancer Center | 2002-02-01 |
| Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function (NCT00137475) | AHS Cancer Control Alberta | 2002-02-01 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer (NCT00027534) | Michael Morse, MD | 2002-01-01 |
| BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer (NCT00057850) | National Cancer Institute (NCI) | 2002-01-01 |
| Subcutaneous Amifostine Safety Study (NCT00158041) | Mt. Sinai Medical Center, Miami | 2002-01-01 |
| Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00030576) | University Health Network, Toronto | 2001-11-01 |
| Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors (NCT00028405) | Light Sciences LLC | 2001-11-01 |
| S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat (NCT00006994) | SWOG Cancer Research Network | 2001-11-01 |
| Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer (NCT00167908) | Washington University School of Medicine | 2001-10-01 |
| Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat (NCT00530088) | Roswell Park Cancer Institute | 2001-10-01 |
| T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC (NCT00609219) | Baylor College of Medicine | 2001-08-01 |
| Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin (NCT00023790) | Case Comprehensive Cancer Center | 2001-08-01 |
| Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor (NCT00021047) | National Institutes of Health Clinical Center (CC) | 2001-07-01 |
| Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer (NCT00024089) | National Cancer Institute (NCI) | 2001-07-01 |
| Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx (NCT00025298) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-07-01 |
| Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer (NCT00014118) | Eastern Cooperative Oncology Group | 2001-06-06 |
| Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer (NCT00017511) | Daiichi Sankyo | 2001-06-01 |
| Thalidomide in Treating Patients With Thyroid Cancer (NCT00026533) | Kenneth Ain | 2001-06-01 |
| Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer (NCT00021424) | National Institute on Deafness and Other Communication Disorders (NIDCD) | 2001-06-01 |
| Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers (NCT00900419) | University of Colorado, Denver | 2001-05-03 |
| Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer (NCT00022594) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-05-01 |
| Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking (NCT00021138) | Personal Improvement Computer Systems | 2001-04-01 |
| ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck (NCT00015964) | University of Chicago | 2001-03-01 |
| Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas (NCT00158691) | Groupe Oncologie Radiotherapie Tete et Cou | 2001-03-01 |
| Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer (NCT00011999) | Radiation Therapy Oncology Group | 2001-03-01 |
| Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer (NCT00017277) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-03-01 |
| Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck (NCT00017498) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-02-01 |
| Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer (NCT00006360) | Radiation Therapy Oncology Group | 2001-02-01 |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer (NCT00006981) | National Cancer Institute (NCI) | 2000-12-01 |
| Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer (NCT00022373) | National Cancer Institute (NCI) | 2000-12-01 |
| SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck (NCT00006361) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer (NCT00006248) | SWOG Cancer Research Network | 2000-11-01 |
| Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer (NCT00022217) | Matrix Pharmaceutical | 2000-11-01 |
| Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer (NCT00006481) | Radiation Therapy Oncology Group | 2000-10-01 |
| Celecoxib in Treating Patients With Precancerous Lesions of the Mouth (NCT00014404) | Memorial Sloan Kettering Cancer Center | 2000-10-01 |
| Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer (NCT00006799) | Wake Forest University Health Sciences | 2000-10-01 |
| Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer (NCT00008398) | Radiation Therapy Oncology Group | 2000-10-01 |
| Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00006471) | M.D. Anderson Cancer Center | 2000-09-01 |
| Contact Allergies to Dental Metal as a Possible Risk Factor for Oral Cancer (NCT00693550) | Mayo Clinic | 2000-08-01 |
| Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors (NCT00005952) | Duke University | 2000-08-01 |
| Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00006107) | Dana-Farber Cancer Institute | 2000-07-14 |
| Radiation Therapy in Treating Patients With Head and Neck Cancer (NCT00021125) | Medical Research Council | 2000-07-01 |